A medicinal chemistry approach for the development of novel anti-tumor agentes by targeting p53-MDM2/X interactions
2019.4.3
Maria M.M. Santos iMed.ULisboa University of Lisbon
11:30h
Euclides Pires Auditorium (UC-Biotech - Cantanhede)
Host: Irina Moreira
Back
 
   
Funded by ERDF - European Regional Development Fund through COMPETE 2020 and National Funds via FCT - Fundação para a Ciência e Tecnologia, under projects POCI-01-0145-FEDER-007440 e UIDB/04539/2020.

© 2020 CNC - Center for Neuroscience and Cell Biology
powered by DigitalWind